Together with evidence of myocardial ischemia, the detection of a rise and/or fall of cardiac biomarkers plays a key role in the diagnosis of myocardial infarction (MI). Cardiac troponins are markers of myocardial necrosis, and because of their high cardiac-specificity, have become the preferred biomarker for the diagnosis of MI.

Learn more about TnI
Videos: High-Sensitivity TnI & Point-of-Care hsTnI

Please contact me with more information about Troponin methods

Reliable Answers to Critical Cardiac Questions

As a recognized worldwide leader in CVD testing, Siemens Healthcare Diagnostics is the only company offering multiple solutions for high-sensitivity troponin I* testing that meets the current guidelines for MI diagnosis.

Features:

• Excellent cardiac specificity
• Greater clinical sensitivity for earlier detection of necrosis and MI
• Solutions for STAT testing - results in as little as 14 minutes
• High-sensitivity cardiac troponin I (TnI)* testing available on central laboratory and point-of-care platforms
• Integrated options so that TnI assays can be run on the same instrument as other STAT chemistry tests

Acute cardiac biomarkers, including TnI and high-sensitivity TnI*, are available on the following systems from Siemens Healthcare Diagnostics:

Overview: systems and acute cardiac biomarkers